Tesamorelin
Indication-Specific Prescription Medication
An FDA-approved GHRH analog for HIV-associated lipodystrophy; not indicated for general weight loss or anti-aging.
Medical information disclaimer
This page is educational only and is not medical advice. It does not describe an approved treatment for every individual and does not guarantee that any product is available for purchase. Investigational compounds are not offered for sale or treatment booking through this storefront. FDA approval applies to specific drug products and indications, not automatically to every formulation containing the same ingredient.
References & Further Reading
- Egrifta WR (tesamorelin) Prescribing Information, updated 2026 — FDA / DailyMedsource
This entry was last reviewed on October 27, 2026 and requires clinical review before publication. ABF's medical and legal advisers may revise research findings and regulatory information as evidence changes.